Kit
receptor
cross-polarisation magic-angle spinning NMR spectroscopy
cross polarization magic angle spinning nuclear magnetic resonance spectroscopy
αERKO
oestrogen receptor alpha knock-out
rHuIFN-alpha-A/D
recombinant human interferon α A/D
transmembrane TNF alpha
transmembrane tumour necrosis factor-α
sCJD
sporadic CJD
HIV type-1 subtype A
human immunodeficiency virus type 1 subtype A
Dfo
desferrioxamine
Rho-GDP dissociation inhibitor-1
Rho-guanine nucleotide dissociation inhibitor 1
vm
mean blood-flow velocity
3-D cell culture system
3-dimensional cell culture system
EHPVO
extrahepatic portal venous obstruction
ER-beta KO
ERβ knock-out
TNF receptor-2
tumour necrosis factor receptor 2
SBE-βCyd
sulphobutyl ether-beta-cyclodextrin
LR
lactated Ringer solution
T-reg cell
regulatory T-cell
CXCL1
CXC motif ligand 1
CPM
continuous passive motion
PP
pseudomyxoma peritonei
NF-kappaB p50 subunit
nuclear factor-κB p50 subunit
PDE5
cGMP-binding cGMP-specific phosphodiesterase
TH-li
Tyrosine hydroxylase-like immunoreactivity
SEM-EDX
scanning electron microscopy-energy dispersive X-ray spectrometry
CFA
configural frequency analysis
SHP2
src homology 2 domain containing protein tyrosine phosphatase 2
RPP
rapidly progressive periodontitis
TGFβ receptor type II
transforming growth factor β receptor type II
alpha BuTX
alpha-bungarotoxin
ORT
oral rehydration therapy
antiIL-4 Ab
antiIL-4 antibody
apn-2
AP endonuclease-2
Ad5E1b
adenovirus 5 E1B
TGFBRI
transforming growth factor β receptor 1
CTnI
cardiac troponin I
BMPRIB
bone morphogenetic protein receptor IB
pk
pneumoconiosis
IL-13 receptor α2-chain
interleukin-13 receptor α 2 chain
G spot
Grafenberg spot
HLA-DR7 antigen
human leukocyte antigen DR7
Ri
intraclass correlation coefficient
Fc ε RI α-chain
type 1 Fcepsilon receptor alpha chain
cirb
colorado institute for research in biotechnology
A-beta
amyloid beta-peptide
IL-1 receptor associated kinase
interleukin 1 receptor associated kinase
AHA
acquired hemolytic anemia
pfmdr-1
Plasmodium falciparum multidrug resistance gene-1
T3
tumor size 3
Ang II level
angiotensin II level
ITT
Intent-to-treat
sPLA(2)IIa
group IIa secretory phospholipase A(2)
SUA
serum uric acid
SmF
submerged fermentation
ebv
epstein-barr virus
ASA-V
American Society of Anesthesiologists Class 5
Tcf-4
T cell factor-4
NG
nitroglycerin
lipox
lipooxygenase
ER-alphaKO
oestrogen receptor alpha knock out
ras-GAP
Ras GTPase-activating protein
DYD
daughter yield deviation
anti-IL 5 MoAb
anti-IL-5 monoclonal antibody
HOG
human oligodendroglioma
CIDR
controlled internal drug-releasing device
LLQ
left lower quadrant
PRX II
peroxiredoxin-II
TAK1 binding protein 1
transforming growth factor-beta-activated kinase 1-binding protein 1
GU
gastric ulcers
IL3R α
IL-3 receptor α chain
PA
puromycin amino-nucleoside
MIP-1 alpha
macrophage-inflammatory protein-1 alpha
TFA
transfer-function analysis
NADPH-cytochrome P450 reductase
nicotinamide adenine dinucleotide phosphate-cytochrome P450 reductase
FRAT
free radical assay technique
MR
Maudsley reactive
